FDA’s Approval of Narcotic Opana is Controversial Because of Questionable Clinical Trial

by Greg Webb
By Greg Webb, May 18, 2015 Opana, manufactured by Endo Pharmaceuticals, is one of a dozen or more narcotic painkillers on the market today. Approved by the FDA in 2006 and again in a reformulated, supposed abuse-free, version in 2011, Opana generated sales of $385 million in 2013. The drug has reportedly brought in from $246 to $640 million in annual sales since 2009.Read the full article